These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 6280298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hemodynamic properties of a new derivative of theophylline: bamifylline].
    Moret PR, Fournet PC, Boufas D.
    Schweiz Med Wochenschr; 1970 Mar 07; 100(10):462-7. PubMed ID: 5423732
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W, Kalkowski H, Günther K, Splith G, Trenckmann H.
    Z Gesamte Inn Med; 1969 Feb 15; 24(4):102-8. PubMed ID: 4978753
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide.
    Proctor JD, Allen FJ, Wasserman AJ.
    Arch Int Pharmacodyn Ther; 1971 Apr 15; 190(2):354-67. PubMed ID: 4396926
    [No Abstract] [Full Text] [Related]

  • 7. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T, Takano M, Tamura A, Kubota H, Suzuki N.
    Masui; 1970 May 15; 19(5):515-22. PubMed ID: 4393894
    [No Abstract] [Full Text] [Related]

  • 8. [The effects of non-depolarizing neuromuscular blocking agents on the cardiac contractility and cardiovascular system (author's transl)].
    Matsukawa S.
    Masui; 1980 Jul 15; 29(7):648-56. PubMed ID: 7411843
    [No Abstract] [Full Text] [Related]

  • 9. [Specific effects of selective anxiolytic afobazole on the cardiovascular system].
    Tsorin IB, Palka IP, Chichkanov GG.
    Eksp Klin Farmakol; 2009 Jul 15; 72(1):41-5. PubMed ID: 19334510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG, McInnes I, Swann JB, Price JM, Carson V, Race D, Lowe TE.
    J Pharmacol Exp Ther; 1968 Jun 15; 161(2):247-61. PubMed ID: 5650138
    [No Abstract] [Full Text] [Related]

  • 12. [On the administration of vasodilator agents following pacemaker implantation].
    Wolner E, Mösslacher H.
    Z Kreislaufforsch; 1968 Mar 15; 57(3):213-23. PubMed ID: 4970182
    [No Abstract] [Full Text] [Related]

  • 13. [Haemodynamic effects of imolamine (author's transl)].
    Rigaud M, Rocha P, Baudet M, Mechmeche R, Beauthier E, Bardet J, Bourdarias JP.
    Ann Cardiol Angeiol (Paris); 1978 Oct 15; 27(5):411-4. PubMed ID: 736481
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of substance P for cardiovascular system (author's transl)].
    Lu DZ.
    Sheng Li Ke Xue Jin Zhan; 1982 Jan 15; 13(1):89-90. PubMed ID: 6179158
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG, Wang HH.
    J Pharmacol Exp Ther; 1980 Feb 15; 212(2):294-303. PubMed ID: 7351643
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.